The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20201581: Centerbridge Capital Partners III, L.P.; Peter Castaldi
20201582: KPS Special Situations Fund V, LP; Garrett Motion Inc.
20201584: Telefonaktiebolaget LM Ericsson; CradlePoint, Inc.
20201585: Red Ventures Holdco, LP; National Amusements, Inc.
20201592: Green Equity Investors Side VIII, L.P.; Warburg Pincus Private Equity XII, L.P.
20201595: GTCR (AP) Investors LP; People's United Financial, Inc.
20201596: ORIX Corporation; John P. Manning
20201597: Accenture plc; Seven Seas Business Ventures, LLC
20201598: Carlyle Partners VII, LP; Tribute Technology Holdings, LLC
20201599: Compass Diversified Holdings; David T. Traitel
Bradley Tewinkle v. Capital One, N.A.
Arko Holdings and Empire Petroleum Partners, In the Matter of
Arko Holdings Ltd. and Empire Petroleum Partners, LLC have agreed to divest retail fuel assets in local gasoline and diesel fuel markets across four states to settle Federal Trade Commission charges that Arko’s proposed acquisition of Empire would violate federal antitrust law. The Commission announced final approval of the consent order in October 2020.
iBackPack of Texas, LLC
Douglas Monahan, operating through his company, iBackPack of Texas, LLC, settled Federal Trade Commission allegations that he operated a deceptive crowdfunding scheme that used contributors’ funds on himself rather than to deliver the high-tech backpack he promised.
16 CFR Part 303: Rules and Regulations Under the Textile Fiber Products Identification Act
One Step Forward, Two Steps Back: Sound Policy on Consumer Protection Fundamentals
Kushly, LLC
In May 2021, The FTC announced a law enforcement action to halt deceptive health and efficacy claims in the growing market for cannabidiol (CBD) products. In the action—the first since the Commission announced a crackdown on such false claims last December—Scottsdale, Arizona-based Kushly Industries LLC (Kushly) and the company’s sole officer Cody Alt agreed not to make false or unsupported claims or falsely claim that scientific evidence exists to back them up. They also paid the FTC more than $30,000 in consumer redress.